Bhyravbhatla N, Alsafwani ZW, Thapa I, Nallasamy P, et al. Targeting oncomucin-driven immunosuppression improves the efficacy of K-ras(G12D) inhibition in pancreatic cancer. Gastroenterology 2026 May 25:S0016-5085(26)06878.
PMID: 42191046